Circulation Research, Vol 72, 312-318, Copyright © 1993 by American Heart Association

ARTICLES

Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II

H Schunkert, JR Ingelfinger, AT Hirsch, Y Pinto, WJ Remme, H Jacob and VJ Dzau
Falk Cardiovascular Research Center, Stanford, Calif.

Although renin and angiotensinogen are known to be subject to feedback regulation, the effects of angiotensin II (Ang II) on the regulation of angiotensin converting enzyme (ACE) gene expression and enzymatic activity have not yet been studied. Therefore, the effects of exogenous Ang II infusion and ACE inhibition on ACE mRNA expression were examined. Ang II was infused intravenously in male Sprague-Dawley rats for 3 days at 100 (low dose), 300 (medium dose), or 1,000 (high dose) ng/kg per minute (n = 8 for each group). Compared with control (vehicle infusion, n = 8), Ang II infusion increased plasma Ang II concentration (62, 101, 126 [p < 0.05], and 187 [p < 0.05] fmol/ml) and mean arterial blood pressure (106, 119 [p < 0.05], 134 [p < 0.05], and 125 mm Hg for control, low, medium, and high doses, respectively). Ang II infusion decreased ACE mRNA levels in the lung (57%, 52%, and 51%; p < 0.05 for each) and testis (49%, 63%, and 53% of control for low, medium, and high doses, respectively; p < 0.05 for each), two major sites of ACE synthesis. There was, albeit less pronounced, a parallel decrease in pulmonary ACE activity (4.38, 3.92, 3.07 [p < 0.05], and 3.48 [p < 0.05] nM/mg per minute for control, medium, and high doses, respectively). In contrast, serum (54, 50, 48, and 38 [p < 0.05] nM/ml per minute) and testicular (2.63, 2.08 [p < 0.05], 2.24, and 2.18 nM/mg per minute for control, low, medium, and high doses, respectively) ACE activities displayed only minimal change in animals infused with Ang II.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				W. J. Cheung, M.-A. H. Kent, E. El-Shahat, H. Wang, J. Tan, R. White, and F. H. H. Leenen Central and peripheral renin-angiotensin systems in ouabain-induced hypertension Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H624 - H630. [Abstract] [Full Text] [PDF]

				M. Paul, A. Poyan Mehr, and R. Kreutz Physiology of local Renin-Angiotensin systems. Physiol Rev, July 1, 2006; 86(3): 747 - 803. [Abstract] [Full Text] [PDF]

				W. Raasch, C. Wittmershaus, A. Dendorfer, I. Voges, F. Pahlke, C. Dodt, P. Dominiak, and O. Johren Angiotensin II Inhibition Reduces Stress Sensitivity of Hypothalamo-Pituitary-Adrenal Axis in Spontaneously Hypertensive Rats Endocrinology, July 1, 2006; 147(7): 3539 - 3546. [Abstract] [Full Text] [PDF]

				B. Westendorp, R. G. Schoemaker, H. Buikema, F. Boomsma, D. J. van Veldhuisen, and W. H. van Gilst Progressive left ventricular hypertrophy after withdrawal of long-term ACE inhibition following experimental myocardial infarction Eur J Heart Fail, March 1, 2006; 8(2): 122 - 130. [Abstract] [Full Text] [PDF]

				A. Jones, S. S. Dhamrait, J. R. Payne, E. Hawe, P. Li, I. S. Toor, L. Luong, P. T.E. Wootton, G. J. Miller, S. E. Humphries, et al. Genetic Variants of Angiotensin II Receptors and Cardiovascular Risk in Hypertension Hypertension, October 1, 2003; 42(4): 500 - 506. [Abstract] [Full Text] [PDF]

				N. K Hollenberg, S. Y Osei, M C. Lansang, D. A Price, and N. D. Fisher Salt intake and non-ACE pathways for intrarenal angiotensin II generation in man Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1): 14 - 18. [Abstract] [PDF]

				J. P. van Kats, D. J. Duncker, D. B. Haitsma, M. P. Schuijt, R. Niebuur, R. Stubenitsky, F. Boomsma, M. A. D. H. Schalekamp, P. D. Verdouw, and A. H. J. Danser Angiotensin-Converting Enzyme Inhibition and Angiotensin II Type 1 Receptor Blockade Prevent Cardiac Remodeling in Pigs After Myocardial Infarction : Role of Tissue Angiotensin II Circulation, September 26, 2000; 102(13): 1556 - 1563. [Abstract] [Full Text] [PDF]

				F. QING, T. J. McCARTHY, J. MARKHAM, and D. P. SCHUSTER Pulmonary Angiotensin-converting Enzyme (ACE) Binding and Inhibition in Humans . A Positron Emission Tomography Study Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 2019 - 2025. [Abstract] [Full Text]

				S. E. Orfanos, J. B. Parkerson, X. Chen, E. L. Fisher, C. Glynos, A. Papapetropoulos, R. G. Gerrity, and J. D. Catravas Reduced lung endothelial angiotensin-converting enzyme activity in Watanabe hyperlipidemic rabbits in vivo Am J Physiol Lung Cell Mol Physiol, June 1, 2000; 278(6): L1280 - L1288. [Abstract] [Full Text] [PDF]

				H. Schunkert The importance of early intervention in CHF -- signs and symptom relief Journal of Renin-Angiotensin-Aldosterone System, March 1, 2000; 1(1_suppl): 17 - 23. [Abstract] [PDF]

				I. M. Straeter-Knowlen, L. J. Dell'italia, J. Dai, G. H. Hankes, A. R. Dillon, R. E. Cartee, G. M. Pohost, and D. D. Ku ACE inhibitors in HF restore canine pulmonary endothelial function and ANG II vasoconstriction Am J Physiol Heart Circ Physiol, November 1, 1999; 277(5): H1924 - H1930. [Abstract] [Full Text] [PDF]

				F. Paillard, D. Chansel, E. Brand, A. Benetos, F. Thomas, S. Czekalski, R. Ardaillou, and F. Soubrier Genotype-Phenotype Relationships for the Renin-Angiotensin-Aldosterone System in a Normal Population Hypertension, September 1, 1999; 34(3): 423 - 429. [Abstract] [Full Text] [PDF]

				S. Kurz, U. Hink, G. Nickenig, A. B. Borthayre, D. G. Harrison, and T. Munzel Evidence for a Causal Role of the Renin-Angiotensin System in Nitrate Tolerance Circulation, June 22, 1999; 99(24): 3181 - 3187. [Abstract] [Full Text] [PDF]

				L. Baruch, I. Anand, I. S. Cohen, S. Ziesche, D. Judd, and J. N. Cohn Augmented Short- and Long-Term Hemodynamic and Hormonal Effects of an Angiotensin Receptor Blocker Added to Angiotensin Converting Enzyme Inhibitor Therapy in Patients With Heart Failure Circulation, May 25, 1999; 99(20): 2658 - 2664. [Abstract] [Full Text] [PDF]

				C. Marie, C. Mossiat, C. Gros, J.-C. Schwartz, J.-M. Lecomte, and J. Bralet Effect of long-term therapy with fasidotril, a mixed inhibitor of neprilysin and angiotensin-converting enzyme (ACE), on survival of rats after myocardial infarction Cardiovasc Res, March 1, 1999; 41(3): 544 - 553. [Abstract] [Full Text] [PDF]

				M. Yano, S. Kim, Y. Izumi, S. Yamanaka, and H. Iwao Differential Activation of Cardiac c-Jun Amino-Terminal Kinase and Extracellular Signal-Regulated Kinase in Angiotensin II–Mediated Hypertension Circ. Res., October 5, 1998; 83(7): 752 - 760. [Abstract] [Full Text] [PDF]

				S R Holmer, H-W Hense, A H J Danser, B Mayer, G A J Riegger, and H Schunkert beta Adrenergic blockers lower renin in patients treated with ACE inhibitors and diuretics Heart, July 1, 1998; 80(1): 45 - 48. [Abstract] [Full Text]

				M. Pfeifer, G. Bruckschlegel, S. R Holmer, M. Paul, A.J.G. Riegger, and H. Schunkert Reciprocal regulation of pulmonary and cardiac angiotensin-converting enzyme in rats with severe left ventricular hypertrophy Cardiovasc Res, April 1, 1998; 38(1): 125 - 132. [Abstract] [Full Text] [PDF]

				O. Costerousse, J. Allegrini, J.-P. Clozel, J. Ménard, and F. Alhenc-Gelas Angiotensin I-Converting Enzyme Inhibition but Not Angiotensin II Suppression Alters Angiotensin I-Converting Enzyme Gene Expression in Vessels and Epithelia J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 1180 - 1187. [Abstract] [Full Text]

				K. T. Weber Extracellular Matrix Remodeling in Heart Failure : A Role for De Novo Angiotensin II Generation Circulation, December 2, 1997; 96(11): 4065 - 4082. [Full Text]

				M. J. Rieder, R. J. Roman, and A. S. Greene Reversal of Microvascular Rarefaction and Reduced Renal Mass Hypertension Hypertension, July 1, 1997; 30(1): 120 - 127. [Abstract] [Full Text]

				E. O. Weinberg, M. A. Lee, M. Weigner, K. Lindpaintner, S. P. Bishop, C. R. Benedict, K. K. L. Ho, P. S. Douglas, E. Chafizadeh, and B. H. Lorell Angiotensin AT1 Receptor Inhibition : Effects on Hypertrophic Remodeling and ACE Expression in Rats With Pressure-Overload Hypertrophy due to Ascending Aortic Stenosis Circulation, March 18, 1997; 95(6): 1592 - 1600. [Abstract] [Full Text]

				F. Diet, R. E. Pratt, G. J. Berry, N. Momose, G. H. Gibbons, and V. J. Dzau Increased Accumulation of Tissue ACE in Human Atherosclerotic Coronary Artery Disease Circulation, December 1, 1996; 94(11): 2756 - 2767. [Abstract] [Full Text]

				G. G. N. Serneri, M. Boddi, M. Coppo, T. Chechi, N. Zarone, M. Moira, L. Poggesi, M. Margheri, and I. Simonetti Evidence for the Existence of a Functional Cardiac Renin-Angiotensin System in Humans Circulation, October 15, 1996; 94(8): 1886 - 1893. [Abstract] [Full Text]

				T. Munzel and E. Bassenge Long-term Angiotensin-Converting Enzyme Inhibition With High-Dose Enalapril Retards Nitrate Tolerance in Large Epicardial Arteries and Prevents Rebound Coronary Vasoconstriction In Vivo Circulation, June 1, 1996; 93(11): 2052 - 2058. [Abstract] [Full Text]

				M. Mai, K. F. Hilgers, J. Wagner, J. F. E. Mann, and H. Geiger Expression of Angiotensin-Converting Enzyme in Renovascular Hypertensive Rat Kidney Hypertension, April 1, 1995; 25(4): 674 - 678. [Abstract] [Full Text]

				G. Bruckschlegel, S. R. Holmer, K. Jandeleit, D. Grimm, F. Muders, E. P. Kromer, G. A. J. Riegger, and H. Schunkert Blockade of the Renin-Angiotensin System in Cardiac Pressure-Overload Hypertrophy in Rats Hypertension, February 1, 1995; 25(2): 250 - 259. [Abstract] [Full Text]